CXCR1 and asthma: Especially, the activation patterns measured in the EMM stick out, as the CXCR1/2 pathways are thought to contribute massively to the development of, among others, prostate, lung, colorectal, and breast cancer, as well as inflammatory diseases such as COPD and asthma [100,101].